{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:34:52Z","timestamp":1790768092063,"version":"4.1.0"},"reference-count":22,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.2967\/jnumed.117.201285","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T20:45:12Z","timestamp":1511556312000},"page":"646-651","source":"Crossref","is-referenced-by-count":10,"title":["Model of Intraperitoneal Targeted \u03b1-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes"],"prefix":"10.2967","volume":"59","author":[{"given":"Stig","family":"Palm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"B\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sture","family":"Lindegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnar","family":"Hultborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Albertsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"2021051712115477000_59.4.646.1","first-page":"383","article-title":"A randomized phase III trial of adjuvant intraperitoneal radioimmunotherapy in ovarian cancer [abstract]","volume":"19","author":"Nicholson","year":"2000","journal-title":"Proc Am Soc Clin Oncol."},{"key":"2021051712115477000_59.4.646.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.5973"},{"key":"2021051712115477000_59.4.646.3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fonc.2013.00324","article-title":"The potential and hurdles of targeted alpha therapy: clinical trials and beyond","volume":"3","author":"Elgqvist","year":"2014","journal-title":"Front Oncol."},{"key":"2021051712115477000_59.4.646.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.167825"},{"key":"2021051712115477000_59.4.646.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.062604"},{"key":"2021051712115477000_59.4.646.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.143842"},{"key":"2021051712115477000_59.4.646.7","first-page":"3914S","article-title":"Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model","volume":"9","author":"Andersson","year":"2003","journal-title":"Clin Cancer Res."},{"key":"2021051712115477000_59.4.646.8","first-page":"1342","article-title":"Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: outcome related to measured tumor size and mean absorbed dose","volume":"47","author":"Elgqvist","year":"2006","journal-title":"J Nucl Med."},{"key":"2021051712115477000_59.4.646.9","first-page":"487","article-title":"Quantification of activity by alpha-camera imaging and small-scale dosimetry within ovarian carcinoma micrometastases treated with targeted alpha therapy","volume":"56","author":"Chouin","year":"2012","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2021051712115477000_59.4.646.10","first-page":"5656","article-title":"Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab\u2032)2, and Fab in tumors","volume":"49","author":"Fujimori","year":"1989","journal-title":"Cancer Res."},{"key":"2021051712115477000_59.4.646.11","first-page":"1288","article-title":"Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention","volume":"63","author":"Graff","year":"2003","journal-title":"Cancer Res."},{"key":"2021051712115477000_59.4.646.12","first-page":"4776","article-title":"An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a \u201cbinding site barrier.\u201d","volume":"51","author":"van Osdol","year":"1991","journal-title":"Cancer Res."},{"key":"2021051712115477000_59.4.646.13","first-page":"2747s","article-title":"Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the \u201cbinding site barrier.\u201d","volume":"52","author":"Weinstein","year":"1992","journal-title":"Cancer Res."},{"key":"2021051712115477000_59.4.646.14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1620"},{"key":"2021051712115477000_59.4.646.15","doi-asserted-by":"publisher","DOI":"10.1118\/1.1640951"},{"key":"2021051712115477000_59.4.646.16","first-page":"1433","article-title":"Distribution of radiolabeled monoclonal antibody MX35 F(ab\u2032)2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer","volume":"3","author":"Finstad","year":"1997","journal-title":"Clin Cancer Res."},{"key":"2021051712115477000_59.4.646.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.07.005"},{"key":"2021051712115477000_59.4.646.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178327"},{"key":"2021051712115477000_59.4.646.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.049833"},{"key":"2021051712115477000_59.4.646.20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-3018"},{"key":"2021051712115477000_59.4.646.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2012.08.034"},{"key":"2021051712115477000_59.4.646.22","first-page":"238","article-title":"Extravascular diffusion in normal and neoplastic tissues","volume":"44","author":"Nugent","year":"1984","journal-title":"Cancer Res."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.117.201285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:24:27Z","timestamp":1621283067000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.117.201285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,2]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.2967\/jnumed.117.201285"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.117.201285","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]}}}